Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
J Fish Dis ; 40(7): 873-884, 2017 Jul.
Article in English | MEDLINE | ID: mdl-27690267

ABSTRACT

Kynurenic acid (KYNA) is an endogenous substance produced on the kynurenine pathway which is primarily known for its neuroactive properties. Recently, it has been proven that KYNA is a selective ligand for G protein-coupled receptor (GPR 35), presented on immunocompetent cells such as T lymphocytes. This opens up new possibilities of its application as an immunostimulating substance in aquaculture. Thus far, no histopathological investigations in fish have been completed to evaluate influence of KYNA supplementation in feed. This study has been undertaken to determine the effect of feed supplementation with KYNA (2.5, 25, 250 mg kg-1 of feed) for 28 days on the liver, gills and kidney in healthy fish and experimentally infected with Yersinia ruckeri. In a control group were observed a fatty liver, which is natural for this fish species in the autumn and winter season. As the dose of the supplement was increased, the fat liver changed, it decreased or completely disappeared. Additionally, inflammatory changes occurred in all the analysed organs, and their intensification was dose dependent. In the fish experimentally infected, KYNA caused aggravation of the signs in the liver, kidneys and gills, and the effect was dose dependent. The results implicate that KYNA may be a stressor for fish.


Subject(s)
Diet/veterinary , Dietary Supplements , Fish Diseases/immunology , Kynurenic Acid , Oncorhynchus mykiss , Yersinia Infections/veterinary , Yersinia ruckeri/physiology , Adjuvants, Immunologic , Animal Feed/analysis , Animals , Dose-Response Relationship, Drug , Fish Diseases/microbiology , Gills/pathology , Kidney/pathology , Liver/pathology , Yersinia Infections/immunology , Yersinia Infections/microbiology
2.
Pol J Vet Sci ; 18(3): 523-31, 2015.
Article in English | MEDLINE | ID: mdl-26618584

ABSTRACT

The aim of this study was to evaluate the effect of low-energy laser irradiation, coenzyme Q10 and vitamin E supplementation on the apoptosis of macrophages and muscle precursor cells during skeletal muscle regeneration after bupivacaine-induced injury. The experiment was conducted on 75 gilts, divided into 5 experimental groups: I--control, II--low-energy laser irradiation, III--coenzyme Q10, IV--coenzyme Q10 and vitamin E, V--vitamin E. Muscle necrosis was induced by injection of 0.5% bupivacaine hydrochloride. The animals were euthanized on subsequent days after injury. Samples were formalin fixed and processed routinely for histopathology. Apoptosis was detected using the TUNEL method. The obtained results indicate that low-energy laser irradiation has a beneficial effect on macrophages and muscle precursor cell activity during muscle post-injury regeneration and protects these cells against apoptosis. Vitamin E has a slightly lower protective effect, limited mainly to the macrophages. Coenzyme Q10 co-supplemented with vitamin E increases the activity of macrophages and muscle precursor cells, myotube and young muscle formation. Importantly, muscle precursor cells seem to be more sensitive to apoptosis than macrophages in the environment of regenerating damaged muscle.


Subject(s)
Apoptosis/drug effects , Lasers , Muscular Diseases/veterinary , Swine Diseases/therapy , Ubiquinone/analogs & derivatives , Vitamin E/pharmacology , Animals , Antioxidants/therapeutic use , Apoptosis/radiation effects , Bupivacaine/toxicity , Dose-Response Relationship, Radiation , Drug Therapy, Combination , Female , Muscle, Skeletal/drug effects , Muscular Diseases/chemically induced , Muscular Diseases/drug therapy , Swine , Ubiquinone/administration & dosage , Ubiquinone/pharmacology , Vitamin E/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL